Download:
pdf |
pdfOMB No. 3117‐0016/USITC No. 20‐1‐4365; Expiration Date: 6/30/2023
(No response is required if currently valid OMB control number is not displayed)
U.S. PRODUCERS’ QUESTIONNAIRE
MATTRESSES FROM CAMBODIA, CHINA, INDONESIA, MALAYSIA,
SERBIA, THAILAND, TURKEY, AND VIETNAM
This questionnaire must be received by the Commission by January 14, 2021
See last page for filing instructions.
The information called for in this questionnaire is for use by the United States International Trade Commission in
connection with its countervailing duty investigation concerning mattresses from China and its antidumping duty
investigations concerning mattresses from Cambodia, Indonesia, Malaysia, Serbia, Thailand, Turkey, and Vietnam (Inv.
Nos. 701‐TA‐645 and 731‐TA‐1495‐1501 (Final)). The information requested in the questionnaire is requested under the
authority of the Tariff Act of 1930, title VII. This report is mandatory and failure to reply as directed can result in a
subpoena or other order to compel the submission of records or information in your firm’s possession (19 U.S.C. §
1333(a)).
Name of firm
Address
City
State
Zip Code
Website
Has your firm produced mattresses (as defined on next page) at any time since January 1, 2017?
NO
(Sign the certification below and promptly return only this page of the questionnaire to the Commission)
YES
(Complete all parts of the questionnaire, and return the entire questionnaire to the Commission)
Return questionnaire via the U.S. International Trade Commission Drop Box by clicking on the
following link: https://dropbox.usitc.gov/oinv/. (PIN: MATT)
CERTIFICATION
I certify that the information herein supplied in response to this questionnaire is complete and correct to the best of my
knowledge and belief and understand that the information submitted is subject to audit and verification by the Commission. By
means of this certification I also grant consent for the Commission, and its employees and contract personnel, to use the
information provided in this questionnaire and throughout this proceeding in any other import‐injury proceedings conducted by
the Commission on the same or similar merchandise.
I, the undersigned, acknowledge that information submitted in response to this request for information and throughout this
proceeding or other proceedings may be disclosed to and used: (i) by the Commission, its employees and Offices, and contract
personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits,
reviews, and evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C.
Appendix 3; or (ii) by U.S. government employees and contract personnel, solely for cybersecurity purposes. I understand that all
contract personnel will sign appropriate nondisclosure agreements.
Name of Authorized Official
Signature
Title of Authorized Official
Phone
Date
Email address
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 2
PART I.‐‐GENERAL INFORMATION
Background.‐‐ This proceeding was instituted in response to petitions filed on March 31, 2020, by
Brooklyn Bedding (Phoenix, Arizona), Corsicana Mattress Company (Dallas, Texas), Elite Comfort
Solutions (Newnan, Georgia), FXI, Inc. (Media, Pennsylvania), Innocor, Inc. (Media, Pennsylvania),
Kolcraft Enterprises, Inc. (Chicago, Illinois), Leggett & Platt, Incorporated (Carthage, Missouri), the
International Brotherhood of Teamsters (Washington, DC), and United Steel, Paper and Forestry,
Rubber, Manufacturing, Energy, Allied Industrial and Service Workers International Union, AFL‐CIO
(Washington, DC). Antidumping and/or countervailing duties may be assessed on the subject imports as
a result of these proceedings if the Commission makes affirmative determinations of injury, threat, or
material retardation, and if the U.S. Department of Commerce (“Commerce”) makes affirmative
determinations of dumping and/or subsidization. Questionnaires and other information pertinent to this
proceeding are available at
https://usitc.gov/investigations/701731/2020/mattresses_cambodia_china_indonesia_malaysia/final.ht
m.
Mattresses covered by these investigations are all types of youth and adult mattresses. The term
“mattress” denotes an assembly of materials that at a minimum includes a “core,” which provides the
main support system of the mattress, and may consist of innersprings, foam, other resilient filling, or a
combination of these materials. Mattresses may also contain: (1) “Upholstery,” the material between
the core and the top panel of the ticking on a single‐sided mattress; or between the core and the top
and bottom panel of the ticking on a double‐sided mattress; and/or (2) “ticking,” the outermost layer of
fabric or other material (e.g., vinyl) that encloses the core and any upholstery, also known as a cover.
The scope of this investigation is restricted to only “adult mattresses” and “youth mattresses.” “Adult
mattresses” are frequently described as “twin,” “extra‐long twin,” “full,” “queen,” “king,” or “California
king” mattresses. “Youth mattresses” are typically described as “crib,” “toddler,” or “youth” mattresses.
All adult and youth mattresses are included regardless of size and size description.
The scope encompasses all types of “innerspring mattresses,” “non‐innerspring mattresses,” and
“hybrid mattresses.” “Innerspring mattresses” contain innersprings, a series of metal springs joined
together in sizes that correspond to the dimensions of mattresses. Mattresses that contain innersprings
are referred to as “innerspring mattresses” or “hybrid mattresses.” “Hybrid mattresses” contain two or
more support systems as the core, such as layers of both memory foam and innerspring units.
“Non‐innerspring mattresses” are those that do not contain any innerspring units. They are generally
produced from foams (e.g., polyurethane, memory (viscoelastic), latex foam, gel‐infused viscoelastic (gel
foam), thermobonded polyester, polyethylene) or other resilient filling.
Mattresses covered by the scope of this investigation may be imported independently, as part of
furniture or furniture mechanisms (e.g., convertible sofa bed mattresses, sofa bed mattresses imported
with sofa bed mechanisms, corner group mattresses, day‐bed mattresses, roll‐away bed mattresses,
high risers, trundle bed mattresses, crib mattresses), or as part of a set in combination with a “mattress
foundation.” “Mattress foundations” are any base or support for a mattress. Mattress foundations are
commonly referred to as “foundations,” “boxsprings,” “platforms,” and/or “bases.” Bases can be static,
foldable, or adjustable. Only the mattress is covered by the scope if imported as part of furniture, with
furniture mechanisms, or as part of a set in combination with a mattress foundation.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 3
Excluded from the scope of this investigation are “futon” mattresses. A “futon” is a bi‐fold frame made
of wood, metal, or plastic material, or any combination thereof, that functions as both seating furniture
(such as a couch, love seat, or sofa) and a bed. A “futon mattress” is a tufted mattress, where the top
covering is secured to the bottom with thread that goes completely through the mattress from the top
through to the bottom, and it does not contain innersprings or foam. A futon mattress is both the bed
and seating surface for the futon.
Also excluded from the scope are airbeds (including inflatable mattresses) and waterbeds, which consist
of air‐ or liquid‐filled bladders as the core or main support system of the mattress.
Also excluded is certain multifunctional furniture that is convertible from seating to sleeping, regardless
of filler material or components, where that filler material or components are upholstered, integrated
into the design and construction of, and inseparable from, the furniture framing, and the outermost
layer of the multifunctional furniture converts into the sleeping surface. Such furniture may, and
without limitation, be commonly referred to as “convertible sofas,” “sofabeds,” “sofa chaise sleepers,”
“futons,” “ottoman sleepers,” or a like description.
Also excluded from the scope of this investigation are any products covered by the existing antidumping
duty orders on uncovered innerspring units from China or Vietnam. See Uncovered Innerspring Units
from the People’s Republic of China: Notice of Antidumping Duty Order, 74 FR 7661 (February 19, 2009);
Uncovered Innerspring Units from the Socialist Republic of Vietnam, 73 FR 75391 (December 11, 2008).
Also excluded from the scope of this investigation are bassinet pads with a nominal length of less than
39 inches, a nominal width less than 25 inches, and a nominal depth of less than 2 inches.
Additionally, also excluded from the scope of this investigation are “mattress toppers.” A “mattress
topper” is a removable bedding accessory that supplements a mattress by providing an additional layer
that is placed on top of a mattress. Excluded mattress toppers have a height of four inches or less.
The products subject to these investigations are currently classifiable under HTSUS statistical reporting
numbers 9404.21.0010, 9404.21.0013, 9404.29.1005, 9404.29.1013, 9404.29.9085, and 9404.29.9087.
Products subject to these investigations may also be reported under HTSUS statistical reporting
numbers 9404.21.0095, 9404.29.1095, 9404.29.9095, 9401.40.0000, and 9401.90.5081. Although the
HTSUS subheadings are provided for convenience and customs purposes, the written description of the
merchandise subject to these investigations is dispositive.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 4
“Mattress innersprings” are a series of metal springs joined together in sizes that correspond to the
dimensions of finished mattresses. Innersprings may be comprised of wrapped coils or open/non‐
wrapped coils. Wrapped innerspring coils consist of coils that are individually encased in a nonwoven or
woven material in rows, which rows are then bound together to form an innerspring. Open/non‐
wrapped coils are generally joined together by helical wire. For purposes of these investigations,
mattresses that contain innersprings are referred to as “innerspring mattresses” or “hybrid mattresses.”
“Innerspring mattresses” are mattresses that contain innersprings, which are a series of metal springs
joined together in sizes that correspond to the dimensions of finished mattresses. Innersprings may be
comprised of wrapped coils or open/non‐wrapped coils. Wrapped innerspring coils consist of coils that
are individually encased in a nonwoven or woven material in rows, which rows are then bound together
to form an innerspring. Open/non‐wrapped coils are generally joined together by helical wire.
“Non‐innerspring mattresses” are mattresses that do not contain any innerspring units. They are
generally produced from foams (e.g., polyurethane, memory (viscoelastic), latex foam, gel‐infused
viscoelastic (gel foam), thermobonded polyester, polyethylene) or other resilient filling.
“Hybrid mattresses” contain two or more support systems as the core, such as layers of both memory
foam and innerspring units.
“Mattress‐in‐a‐box” (“MiBs”) are mattresses of any size, with or without innersprings, that are rolled
and compressed, whether or not further packaged in plastic or other packaging material for delivery in
the compressed state to the ultimate consumer purchaser. These mattresses may be referred to by a
variety of names, including “mattresses in a box,” “MiBs,” or “bed in a box.”
“Non‐MiB” are all mattresses not covered by the definition of MiB above. They include mattresses of
any size, with or without innersprings, that are NOT both rolled and compressed. These mattresses,
which may or may not be compressed, are sometimes referred to as “flat‐packed” mattresses (“FPM”).
“Crib mattresses” have a width exceeding 27 inches, a length exceeding 51 inches, and a depth between
1 inch and 6 inches inclusive, on a nominal basis. Such mattresses are typically designed to fit USA
standard full‐size cribs.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 5
Reporting of information.‐‐If information is not readily available from your records, provide carefully
prepared estimates. If your firm is completing more than one questionnaire (i.e., a producer, importer,
and/or purchaser questionnaire), you need not respond to duplicated questions.
Confidentiality.‐‐The commercial and financial data furnished in response to this questionnaire that
reveal the individual operations of your firm will be treated as confidential by the Commission to the
extent that such data are not otherwise available to the public and will not be disclosed except as may
be required by law (see 19 U.S.C. § 1677f). Such confidential information will not be published in a
manner that will reveal the individual operations of your firm; however, general characterizations of
numerical business proprietary information (such as discussion of trends) will be treated as confidential
business information only at the request of the submitter for good cause shown.
Verification.‐‐The information submitted in this questionnaire is subject to audit and verification by the
Commission. To facilitate possible verification of data, please keep all files, worksheets, and supporting
documents used in the preparation of the questionnaire response. Please also retain a copy of the final
document that you submit.
Release of information.‐‐The information provided by your firm in response to this questionnaire, as
well as any other business proprietary information submitted by your firm to the Commission in
connection with this proceeding, may become subject to, and released under, the administrative
protective order provisions of the Tariff Act of 1930 (19 U.S.C. § 1677f) and section 207.7 of the
Commission’s Rules of Practice and Procedure (19 CFR § 207.7). This means that certain lawyers and
other authorized individuals may temporarily be given access to the information for use in connection
with this proceeding or other import‐injury proceedings conducted by the Commission on the same or
similar merchandise; those individuals would be subject to severe penalties if the information were
divulged to unauthorized individuals.
D‐GRIDS tool.‐‐The Commission has a tool that firms can use to move data from their own MS Excel
compilation files into self‐contained data tables within this MS Word questionnaire, thereby reducing
the amount of cell‐by‐cell data entry that would be required to complete this form. This tool is a macro‐
enabled MS Excel file available for download from the Commission's generic questionnaires webpage
(https://www.usitc.gov/trade_remedy/question.htm) called the “D‐GRIDs tool.” Use of this tool to help
your firm complete this questionnaire is optional. Firms opting to use the D‐GRIDs tool to populate their
data into this questionnaire will need the D‐GRIDs specification sheet PDF file specific to this proceeding
(available on the case page which is linked under the “Background” above) which includes the necessary
references relating to this questionnaire, as well as the macro‐enable MS Excel D‐GRIDs tool itself from
the generic questionnaires page. More detailed instructions on how to use the D‐GRIDs tool are
available within the D‐GRIDs tool itself.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
I‐1a.
Page 6
OMB statistics.‐‐Please report below the actual number of hours required and the cost to your
firm of completing this questionnaire.
Hours
Dollars
The questions in this questionnaire have been reviewed with market participants to ensure that
issues of concern are adequately addressed and that data requests are sufficient, meaningful,
and as limited as possible. Public reporting burden for this questionnaire is estimated to average
50 hours per response, including the time for reviewing instructions, gathering data, and
completing and reviewing the questionnaire.
We welcome comments regarding the accuracy of this burden estimate, suggestions for
reducing the burden, and any suggestions for improving this questionnaire. Please attach such
comments to your response or send to the Office of Investigations, USITC, 500 E St. SW,
Washington, DC 20436.
I‐1b.
TAA information release.‐‐In the event that the U.S. International Trade Commission (USITC)
makes an affirmative final determination in this proceeding, do you consent to the USITC's
release of your contact information (company name, address, contact person, contact person’s
title, telephone number, email address) appearing on the front page of this questionnaire to the
Departments of Commerce, Labor, and Agriculture, as applicable, so that your firm and its
workers can be made eligible for benefits under the Trade Adjustment Assistance program?
Yes
No
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
I‐2a.
Page 7
Establishments covered.‐‐Provide the city, state, zip code, and brief description of each
establishment covered by this questionnaire. Firms operating more than one establishment
should combine the data for all establishments into a single report.
“Establishment”‐‐Each facility of a firm involved in the production of mattresses, including
auxiliary facilities operated in conjunction with (whether or not physically separate from) such
facilities.
Establishments
City, State
Zip (5 digit)
Description
covered1
1
I‐2b.
I‐2c.
1
2
3
4
5
6
Additional discussion on establishments consolidated in this questionnaire: .
Stock symbol information.‐‐ If your firm or parent firm is publicly traded, please specify the
stock exchange and trading symbol: .
External counsel.‐‐ If your firm or parent firm is represented by external counsel in relation to
this proceeding, please specify the name of the law firm and the lead attorney(s).
I‐3.
Law firm:
Lead attorney(s):
Petitioner status.‐‐Is your firm a petitioner in this proceeding or a member firm of the
petitioning entity?
No
Yes
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
I‐4.
Page 8
Petition support.‐‐Does your firm support or oppose the petitions?
Country
Investigation type
Cambodia
AD
China
CVD
Indonesia
AD
Malaysia
AD
Serbia
AD
Thailand
AD
Turkey
AD
Vietnam
AD
I‐5.
Support
Oppose
Take no position
Ownership.‐‐Is your firm owned, in whole or in part, by any other firm?
No
Yes‐‐List the following information, relating to the ultimate parent/owner.
Extent of
ownership
(percent)
Firm name
Country
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
I‐6.
I‐7.
Page 9
Related importers/exporters.‐‐Does your firm have any related firms, either domestic or
foreign, that are engaged in importing mattresses from Cambodia, China, Indonesia, Malaysia,
Serbia, Thailand, Turkey, and/or Vietnam into the United States or that are engaged in exporting
mattresses from Cambodia, China, Indonesia, Malaysia, Serbia, Thailand, Turkey, and/or
Vietnam to the United States?
No
Yes‐‐List the following information.
Firm name
Country
Affiliation
Related producers.‐‐Does your firm have any related firms, either domestic or foreign, that are
engaged in the production of mattresses?
No
Yes‐‐List the following information.
Firm name
Country
Affiliation
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 10
PART II.‐‐TRADE AND RELATED INFORMATION
Further information on this part of the questionnaire can be obtained from Mary Messer
([email protected]; 202‐205‐3193). Supply all data requested on a calendar‐year basis.
II‐1. Contact information.‐‐Please identify the responsible individual and the manner by which
Commission staff may contact that individual regarding the confidential information submitted
in Part II.
Name
Title
Email
Telephone
II‐2a. Changes in operations.‐‐Please indicate whether your firm has experienced any of the following
changes in relation to the production of mattresses since January 1, 2017.
(check as many as appropriate) (If checked, please describe the nature, date(s), and
significance of any such reported changes as well as the
business reasons for them; leave completely blank if not
applicable)
plant openings
plant closings
relocations
expansions
acquisitions
consolidations
prolonged shutdowns or
production curtailments
revised labor agreements
other (e.g., technology)
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 11
II‐2b. COVID‐19 pandemic.‐‐ Since January 1, 2020, has the COVID‐19 pandemic or have any
government actions taken to contain the spread of the COVID‐19 virus resulted in changes in
relation to your firm's supply chain arrangements, production, employment, and sales relating
to mattresses?
No
Yes
If yes, describe these changes including a separate discussion of the (a)
supply chain impact, (b) production and sales impact, and (c)
employment impact of the COVID‐19 pandemic.
II‐3a. Production using same machinery.‐‐Please report your firm’s production of products using the
same equipment, machinery, or employees as used to produce mattresses, and the combined
production capacity on this shared equipment, machinery, or employees in the periods
indicated.
“Overall production capacity” or “capacity” – The level of production that your
establishment(s) could reasonably have expected to attain during the specified periods. Assume
normal operating conditions (i.e., using equipment and machinery in place and ready to
operate; normal operating levels (hours per week/weeks per year) and time for downtime,
maintenance, repair, and cleanup).
Note.‐‐If your firm does not produce any out‐of‐scope merchandise on the same machinery and
equipment as scope merchandise then the "overall production capacity" numbers reported in
this question should be exactly equal to the "average production capacity" numbers reported in
question II‐7. If, however, your firm does produce out‐of‐scope merchandise using the same
machinery and equipment as scope merchandise, then the "average production capacity"
reported in question II‐7 should exclude the portion of "overall production capacity" that was
used to produce this out‐of‐scope merchandise.
“Production” – All production in your U.S. establishment(s), including production consumed
internally within your firm and production for another firm under a toll agreement.
Quantity (in number)
Calendar year
Item
2017
1
Overall production capacity
Production of:
Mattresses2
3
Out‐of‐scope production
Total production using same
machinery or workers
1
2018
January‐September
2019
2019
2020
0
0
0
0
0
0
0
0
0
0
Data reported for capacity (first line) should be greater than data reported for total production (last line).
Data entered for production of mattresses will populate here once reported in question II‐7.
3
Please identify these products: .
2
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 12
II‐3b. Operating parameters.‐‐The production capacity reported in II‐3a is based on the following
operating parameters:
Weeks per year1
Shifts per week1
Hours per week1
1
Please explain any variations in these operating parameters over the period from January 2017 to
September 2020: .
II‐3c.
Capacity calculation.‐‐Please describe the methodology used to calculate overall production
capacity reported in II‐3a, and explain any changes in reported capacity.
II‐3d. Production constraints.‐‐Please describe the constraint(s) that set the limit(s) on your firm’s
production capacity.
II‐4.
Product shifting.—
(a)
Is your firm able to switch production (capacity) between mattresses and other products
using the same equipment and/or labor?
No
Yes
If yes—(i.e., have produced other products or are able to produce other
products) Please identify other actual or potential products.
(b)
Please describe the factors that affect your firm’s ability to shift production capacity
between products (e.g., time, cost, relative price change, etc.), and the degree to which
these factors enhance or constrain such shifts.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
II‐5.
Page 13
Tolling.‐‐Since January 1, 2017, has your firm been involved in a toll agreement regarding the
production of mattresses?
“Toll agreement”‐‐Agreement between two firms whereby the first firm furnishes the raw
materials and the second firm uses the raw materials to produce a product that it then returns
to the first firm with a charge for processing costs, overhead, etc.
II‐6.
No
Yes
If yes‐‐Please describe the toll arrangement(s) and name the firm(s)
involved.
Foreign trade zones.‐‐
(a)
Firm's FTZ operations.‐‐Does your firm produce mattresses in and/or admit mattresses
into a foreign trade zone (FTZ)?
“Foreign trade zone” is a designated location in the United States where firms utilize
special procedures that allow delayed or reduced customs duty payments on foreign
merchandise. A foreign trade zone must be designated as such pursuant to the rules and
procedures set forth in the Foreign‐Trade Zones Act.
No
Yes
If yes‐‐Describe the nature of your firm’s operations in FTZs and identify
the specific FTZ site(s).
(b)
Other firms' FTZ operations.‐‐To your knowledge, do any firms in the United States
import mattresses into a foreign trade zone (FTZ) for use in distribution of mattresses
and/or the production of downstream articles?
No
Yes
If yes‐‐Identify the firms and the FTZs.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
II‐7.
Page 14
Production, shipment, and inventory data.‐‐Report your firm’s production capacity, production,
shipments, and inventories related to the production of mattresses in its U.S. establishment(s)
during the specified periods.
“Average production capacity” or “capacity” – The level of production that your
establishment(s) could reasonably have expected to attain during the specified periods. Assume
normal operating conditions (i.e., using equipment and machinery in place and ready to
operate; normal operating levels (hours per week/weeks per year) and time for downtime,
maintenance, repair, and cleanup; and a typical or representative product mix).
“Production” – All production in your U.S. establishment(s), including production consumed
internally within your firm and production for another firm under a toll agreement.
“Commercial U.S. shipments” –Shipments made within the United States as a result of an arm’s
length commercial transaction in the ordinary course of business. Report net values (i.e., gross
sales values less all discounts, allowances, rebates, prepaid freight, and the value of returned
goods) in U.S. dollars, f.o.b. your point of shipment. For the purposes of this questionnaire,
commercial U.S. shipments should include (a) sales to distributors, (b) sales to retailers, and
(c) commercial sales to end users; but should not include retail level sales made to individual
customers through your firm's own retail establishments (either brick‐and‐mortar stores or
online order fulfillment centers).
“Internal consumption, including product shipped to own firm's retail establishments”‐‐
Product consumed internally by your firm, which includes merchandise that your firm
transferred to your own firm’s retail establishments (i.e., shipped to either a brick‐and‐mortar
store or to an online order fulfillment center). Such transactions are to be valued at fair market
value and not the total value of final downstream processed merchandise in the case of internal
consumption, nor the retail sale value in the case of your firm owning and operating its own
retail establishments or using a third‐party fulfillment center to fulfill retail level sales.
“Transfers to related firms” –Shipments made to related firms. Such transactions are valued at
fair market value.
“Related firm” –A firm that your firm solely or jointly owned, managed, or otherwise controlled;
a firm that solely or jointly owned, managed, or otherwise controlled your firm; and/or a firm
that was solely or jointly owned, managed, or otherwise controlled by a firm that also solely or
jointly owned, managed, or otherwise controlled your firm.
“Export shipments” –Shipments to destinations outside the United States, including shipments
to related firms.
“Inventories”— Finished goods inventory, not raw materials or work‐in‐progress.
Note: As requested in Part I of this questionnaire, please keep all supporting documents/records used in
the preparation of the trade data, as Commission staff may contact your firm regarding questions on the
trade data. The Commission may also request that your company submit copies of the supporting
documents/records (such as production and sales schedules, inventory records, etc.) used to compile
these data.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
II‐7.
Page 15
Production, shipment, and inventory data.‐‐Continued
Quantity (in number of mattresses) and value (in $1,000)
Calendar year
Item
2017
1
2018
January‐September
2019
2019
2020
Average production capacity (quantity) (A)
Beginning‐of‐period inventories (quantity) (B)
Production (quantity) (C)
U.S. shipments:
Commercial U.S. shipments:
Quantity (D)
Value (E)
Internal consumption, including product
shipped to your firm's retail establishments:2
Quantity (F)
Value2 (G)
Transfers to related firms:
Quantity (H)
2 3
2
Value (I)
Export shipments:4
Quantity (J)
Value (K)
End‐of‐period inventories (quantity) (L)
1
The production capacity reported is based on the following operating parameters: hours per week,
weeks per year, and shifts per week. Please explain any variations in these operating parameters over the period
January 2017 to September 2020: . Please describe the methodology used to calculate production capacity, and
explain any changes in reported capacity .
2
Internal consumption and transfers to related firms must be valued at fair market value. If your firm uses a different
basis for valuing these transactions in your records, please specify that basis (e.g., cost, cost plus, etc.): . However,
the data provided above in this table should be based on fair market value.
3
Please: (a) identify the related firms; (b) indicate the nature of the relationship between your firm and the related
firms (e.g., joint venture, wholly owned subsidiary, et cetera), (c) indicate whether the transfers were recorded in your
books and records at fair market value or other, non‐market formula; and (d) indicate whether your firm retained
marketing rights to all transfers, and whether the related firms also processed inputs from sources other than your firm.
.
4
Identify your firm’s principal export markets: .
RECONCILIATION OF SHIPMENTS, PRODUCTION, AND INVENTORY.‐‐Generally, the data reported for the end‐of‐
period inventories (i.e., line L) should be equal to the beginning‐of‐period inventories (i.e., line B), plus
production (i.e., line C), less total shipments (i.e., lines D, F, H, and J). Please ensure that any differences are not
due to data entry errors in completing this form, but rather reflect your firm’s actual records; and, also provide
explanations for any differences (e.g., theft, loss, damage, record systems issues, etc.) if they exist.
Calendar year
Reconciliation
B + C – D – F – H – J – L = should equal
zero ("0") or provide an explanation.1
1
2017
0
2018
0
January‐September
2019
0
2019
2020
0
Explanation if the calculated fields above are returning values other than zero (i.e., “0”) but are nonetheless
accurate: .
0
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
II‐8.
Page 16
U.S. shipments, by channels of distribution and by type (MiB/Non‐MiB).‐‐Report your firm’s
U.S. shipments (i.e. inclusive of commercial U.S. shipments, internal consumption, and transfers
to related firms) by channel of distribution and by type (MiB/Non‐MiB).
“Brick and mortar” – U.S. shipments (i.e. inclusive of commercial U.S. shipments, internal
consumption, and transfers to related firms) to retailers that resell mattresses to consumers in
physical stores. Also include mattresses shipped/transferred to your own firm's retail
establishments.
“Internet/online” – U.S. shipments (i.e. inclusive of commercial U.S. shipments, internal
consumption, and transfers to related firms) to retailers that resell mattresses to consumers
over the internet. Also include mattresses shipped/transferred for your own firm’s
online/internet sales.
“Omni‐channel” – U.S. shipments (i.e. inclusive of commercial U.S. shipments, internal
consumption, and transfers to related firms) shipments to retailers that resell mattresses to
consumers in both physical brick and mortar stores and over the internet.
“Distributors” – U.S. shipments (i.e. inclusive of commercial U.S. shipments, internal
consumption, and transfers to related firms) to unrelated entities that resell mattresses to
retailers that then resell the mattresses to consumers.
“End users” – U.S. shipments (i.e. inclusive of commercial U.S. shipments, internal consumption,
and transfers to related firms) to business/corporate/institutional end users (for example,
hotels, hospitality businesses, medical entities, and government entities).
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
II‐8.
Page 17
U.S. shipments, by channels of distribution and by type (MiB/Non‐MiB). —Continued
Quantity (in number of mattresses)
Calendar year
Item
U.S. shipments:
MiBs:
Retail:
Brick and mortar (M)
2017
2018
January‐September
2019
2019
2020
Internet/online (N)
Omni‐channel (O)
Subtotal, retail
0
0
0
0
0
Distributors (P)
End users (Q)
Internet/online (S)
Omni‐channel (T)
Subtotal, retail
0
0
0
0
0
Distributors (U)
End users (V)
Non‐MiBs:
Retail:
Brick and mortar (R)
RECONCILIATION OF CHANNELS.‐‐Please ensure that the quantities reported for channels of distribution (i.e.,
lines M through V) in each time period equal the quantity reported for U.S. shipments (i.e., line D, F, H) in each
time period. If the calculated fields below return values other than zero (i.e., “0”), the data reported must be
revised prior to submission to the Commission.
Calendar year
Reconciliation
M + N + O + P + Q + R + S + T + U +
V ‐ D ‐ F‐ H = zero ("0"), if not
revise.
2017
0
2018
January‐September
2019
0
2019
0
2020
0
0
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
II‐9.
Page 18
U.S. shipments, by product type.‐‐Report your firm’s U.S. shipments (i.e., inclusive of
commercial U.S. shipments, internal consumption, and transfers to related firms) by product
type.
Quantity (in number of mattresses) and value (in $1,000)
Calendar year
Item
U.S. shipments:
MiB:
Innerspring:
Quantity (W)
2017
2018
January‐September
2019
2019
2020
Hybrid:
Quantity (AA)
Value (AB)
Value (AD)
Non‐innerspring:
Quantity (AE)
Value (AF)
Hybrid:
Quantity (AG)
Value (AH)
Value (X)
Non‐innerspring:
Quantity (Y)
Value (Z)
Non‐MiB:
Innerspring:
Quantity (AC)
RECONCILIATION OF SHIPMENTS.‐‐Please ensure that the quantities and values of U.S. shipments by
product type (i.e., lines W through AH) in each period in this question are equal to the quantities and
values reported for U.S. shipments (i.e., lines D though I) in each time period from question II‐7. If the
calculated fields below return values other than zero (i.e., “0”), the data reported must be revised prior
to submission to the Commission.
Calendar year
January‐September
Reconciliation
Quantity: W + Y + AA +
AC + AE + AG – D – F – H
= zero ("0"). If not,
revise.
Value: X + Z + AB + AD
+ AF + AH – E – G – I =
zero ("0"). If not, revise.
2017
2018
2019
2019
2020
0
0
0
0
0
0
0
0
0
0
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 19
II‐10. Capacity and production of MiBs.‐‐Report your firm’s capacity and production of MiBs in the
specified periods. If your firm only produces MiBs, these data should match question II‐7; If
your firm does not produce any MiBs, these data should be reported as zeroes; if you firm
produces both MiBs and non‐MiBs (or FPM), these data should be a subset of what your firm
reported in question II‐7.
Quantity (in number of mattresses)
Calendar year
Item
2017
MiB:
Capacity1 2
2 3
Production
January‐September
2018
2019
2019
2020
1
What defines or constrains your firm's reported capacity to produce MiBs above?
Rolling capacity. Other (specify ).
2
Is your firm able to switch production (capacity) between MiB and non‐MiB (or FPM) using the same equipment
and/or labor? Yes. No.‐‐If no, please indicate what limits your firm's ability to shift between MiB and non‐MiB (or
FPM) production. .
3
Does the packaging method (MiB vs non‐MiB) limit the interchangeability of the mattress from the end‐use customer
perspective? No. Yes.‐‐If yes, please indicate how the packaging type limits end use interchangeability: .
II‐11. U.S. shipments, by size.‐‐Report your firm’s U.S. shipments (i.e. inclusive of commercial U.S.
shipments, internal consumption, and transfers to related firms) by size in the specified periods.
Quantity (in number of mattresses) and value (in $1,000)
Calendar year
Item
2017
U.S. shipments:
Crib mattresses:
Quantity
Value
2018
January‐September
2019
2019
2020
0
0
0
0
0
0
0
0
0
0
1
All other mattresses:
Quantity
Value
1
Data will populate into these lines from data entered into question II‐7 and will remove the crib mattress data
reported above in this question. Calculated fields should not result in negative numbers. If negative numbers get
calculated under "All other mattresses", please revise the reported data to eliminate the negative numbers prior to
submission to the Commission.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 20
II‐12. Employment data.‐‐Report your firm’s employment‐related data related to the production of
mattresses and provide an explanation for any trends in these data.
“Production and Related Workers” (PRWs) includes working supervisors and all nonsupervisory
workers (including group leaders and trainees) engaged in fabricating, processing, assembling,
inspecting, receiving, storage, handling, packing, warehousing, shipping, trucking, hauling,
maintenance, repair, janitorial and guard services, product development, auxiliary production
for plant’s own use (e.g., power plant), recordkeeping, and other services closely associated with
the above production operations.
Average number employed may be computed by adding the number of employees, both full
time and part time, for the 12 pay periods ending closest to the 15th of the month and divide
that total by 12. For the January to September periods, calculate similarly and divide by 9.
If your firm had the same number of PRWs in all Calendar year and had not experienced
any changes in PRWs in the most recent interim period, you would have the same
number of PRWs for the interim periods, regardless of whether the interim periods are
Jan‐Mar (Q1), Jan‐June (Q1+Q2), or Jan‐Sept (Q1+Q2+Q3).”
“Hours worked” includes time paid for sick leave, holidays, and vacation time. Include overtime
hours actually worked; do not convert overtime pay to its equivalent in straight time hours.
“Wages paid” –Total wages paid before deductions of any kind (e.g., withholding taxes, old‐age
and unemployment insurance, group insurance, union dues, bonds, etc.). Include wages paid
directly by your firm for overtime, holidays, vacations, and sick leave.
Calendar year
January‐September
Item
2017
2018
2019
2019
2020
Average number of PRWs (number)
Hours worked by PRWs (1,000 hours)
Wages paid to PRWs ($1,000)
Explanation of trends in employment data reported:
II‐13. Related firms.‐‐If your firm reported transfers to related firms in question II‐7, please identify
the firm(s) and indicate the nature of the relationship between your firm and the related firms
(e.g., joint venture, wholly owned subsidiary), whether the transfers were priced at market
value or by a non‐market formula, whether your firm retained marketing rights to all transfers,
and whether the related firms also processed inputs from sources other than your firm.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 21
II‐14. Purchases.‐‐Has your firm purchased mattresses produced in the United States or in other
countries since January 1, 2017? (Do not include imports for which your firm was the importer
of record. These should be reported in an importer questionnaire.)
“Purchase” – A transaction to buy product from a U.S. corporate entity such as another U.S.
producer, a U.S. distributor, or a U.S. firm that has directly imported the product.
“Import” –A transaction to buy from a foreign supplier where your firm is the importer of
record.
No
Yes
If yes‐‐Report such purchases in the table below and explain the reasons
for your firms' purchases.
Note: If your firm served as the importer of record for any purchases from foreign suppliers,
either for your own account or as a service for another entity, those purchases are to be
considered "imports" not "purchases" and should not be included in the table below
(Quantity in number of mattresses)
Calendar year
Item
2017
2018
January‐September
2019
2019
2020
1
Purchases from U.S. importers of
mattresses from—
Cambodia
China
Indonesia
Malaysia
Serbia
Thailand
Turkey
Vietnam
All other sources
Purchases from domestic producers
3
Purchases from other sources
2
1
Please list the name of the importer(s) from which your firm purchased this product. If your firm’s import
suppliers differ by source, please identify the source for each listed supplier: .
2
Please list the name of the U.S. producer(s) from which your firm purchased this product: .
3
Please list the name of the firm(s) from which your firm purchased this product: .
II‐15. Imports.‐‐Since January 1, 2017, has your firm imported mattresses?
No
Yes
If yes‐‐COMPLETE AND RETURN A U.S. IMPORTERS’ QUESTIONNAIRE
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 22
II‐16. Other explanations.‐‐If your firm would like to further explain a response to a question in Part II
for which a narrative box was not provided, please note the question number and the
explanation in the space provided below. Please also use this space to highlight any issues your
firm had in providing the data in this section, including but not limited to technical issues with
the MS Word questionnaire.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 23
PART III.‐‐FINANCIAL INFORMATION
Address questions on this part of the questionnaire to Emily Kim (202‐205‐1800, [email protected])
III‐1. Contact information.‐‐Please identify the responsible individual and the manner by which
Commission staff may contact that individual regarding the confidential information submitted
in Part III.
Name
Title
Email
Telephone
III‐2. Accounting system.—Please provide the following information on your firm’s financial
accounting system.
A.
When does your firm’s fiscal year end (month and day)?
If your firm’s fiscal year changed during the data‐collection period, explain
below:
B.1. Describe the lowest level of operations (e.g., plant, division, company‐wide) for
which financial statements are prepared that include mattresses:
2. Does your firm prepare profit/loss statements for mattresses:
Yes
No
3. How often did your firm (or parent company) prepare financial statements
(including annual reports, 10Ks)? Please check relevant items below.
Audited, unaudited, annual reports, 10Ks, 10 Qs,
Monthly, quarterly, semi‐annually, annually
4. Accounting basis:
U.S. GAAP, IFRS, cash, tax, or
other comprehensive basis of accounting (specify)
Note: As requested in Part I of this questionnaire, please keep all supporting documents/records
used in the preparation of the financial data, as Commission staff may contact your firm
regarding questions on the financial data. The Commission may also request that your company
submit copies of the supporting documents/records (financial statements, including internal
profit‐and‐loss statements for the division or product group that includes mattresses, as well as
specific statements and worksheets) used to compile these data.
III‐3.
Cost accounting system.‐‐Briefly describe your firm’s cost accounting system (e.g., standard
cost, job order cost, etc.).
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
III‐4.
Page 24
Allocation basis.‐‐Briefly describe your firm’s allocation basis, if any, for COGS, SG&A, and
interest expense and other income and expenses.
III‐5.
Product listing.‐‐Please list the products your firm produced in the facilities in which your firm
produced mattresses and provide the share of net sales accounted for by these products in your
firm’s most recent fiscal year.
Products
Share of sales
Mattresses
%
%
%
%
%
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
III‐6.
Page 25
Inputs from related suppliers.‐‐Does your firm purchase inputs (raw materials, labor, energy, or
any services) used in the production of mattresses from any related suppliers (e.g., inclusive of
transactions between related firms, divisions and/or other components within the same
company)?
Yes‐‐Continue to question III‐7
III‐7.
No—Skip to question III‐9a.
Inputs from related suppliers detailed.‐‐Please identify the inputs used in the production of
mattresses that your firm purchases from related suppliers and that are reflected in question III‐
9a. For “Share of total COGS” please report this information by relevant input on the basis of
your most recently completed fiscal year. For “Input valuation” please describe the basis, as
recorded in your company’s own accounting system, of the purchase cost from the related
supplier; e.g., the related supplier’s actual cost, cost plus, negotiated transfer price to
approximate fair market value.
Input
Related supplier
Share of total COGS
Input valuation as recorded in the firm’s accounting books and records
III‐8.
Inputs purchased from related suppliers.‐‐Please confirm that the inputs purchased from
related suppliers, as identified in question III‐7, are reported in question III‐9a (financial results
on mattresses) in a manner consistent with your firm’s accounting books and records.
Yes
No
If no‐‐In the space below, please report the valuation basis of inputs
purchased from related suppliers as reported in question III‐9a.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 26
III‐9a. Operations on mattresses.‐‐Report the revenue and related cost information requested below
on the mattresses operations of your firm’s U.S. establishment(s).1 Do not report resales of
products. Note that internal consumption and transfers to related firms must be valued at fair
market value. Input purchases from related suppliers should be consistent with and based on
information in the firm’s accounting books and records. Provide data for your firm’s three most
recently completed fiscal years, and for the specified interim periods. If your firm was involved
in tolling operations (either as the toller or as the tollee), please contact Emily Kim at (202) 205‐
1800 before completing this section of the questionnaire.
Quantity (in number of mattresses) and value (in $1,000)
Fiscal years ended‐‐
Item
2017
2018
January‐September
2019
2019
2020
2
Net sales quantities:
Commercial sales (“CS”)
Internal consumption (“IC”), including
product shipped to your firm's retail
establishments
Transfers to related firms (“Transfers”)
0
0
0
0
0
IC, including product shipped to your
firm's retail establishments
Transfers to related firms
Total net sales values
0
0
0
0
0
Direct labor
Other factory costs
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total net sales quantities
2
Net sales values:
Commercial sales
3
Cost of goods sold (COGS):
Raw materials
Total COGS
Gross profit or (loss)
Selling, general, and administrative (SG&A)
expenses
Operating income (loss)
Other expenses and income:
Interest expense
4
All other expense and income items, net
Net income or (loss) before income taxes
Depreciation/amortization included above
1 Include only sales (whether domestic or export) and costs related to your U.S. manufacturing operations.
2 Less discounts, returns, allowances, and prepaid freight. The quantities and values should approximate the corresponding
shipment quantities and values reported in Part II of this questionnaire.
3 COGS (whether for domestic or export sales) should include costs associated with CS, IC, and Transfers.
4 If the total reported amount is net other expenses, report as a positive number. If the total reported amount is net other
income, report as a negative number. Please check the calculated “Net income or (loss) before income taxes” to ensure proper
reporting of these items.
Note ‐‐The table above contains calculations that will appear when you have entered data in the MS
Word form fields.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 27
III‐9b. Financial data reconciliation.‐‐The calculable line items from question III‐9a (i.e., total net sales
quantities and values, total COGS, gross profit (or loss), operating income (or loss) and net
income (or loss)) have been calculated from the data submitted in the other line items. Do the
calculated fields return the correct data according to your firm's financial records ignoring non‐
material differences that may arise due to rounding?
Yes
No
If no‐‐If the calculated fields do not show the correct data, please double
check the feeder data for data entry errors and revise. Also, check signs
accorded to the post operating income line items; the two expense line
items should report positive numbers (i.e., expenses are positive and
incomes or reversals are negative‐‐instances of the latter should be rare in
those lines) while the income line item also in most instances should have
its value be a positive number (i.e., income is positive, expenses or reversals
are negative). If after reviewing and potentially revising the feeder data
your firm has provided, the differences between your records and the
calculated fields persist please identify and discuss the differences in the
space below.
III‐9c. Raw materials.‐‐Please report the share of total raw material costs in 2019 (reported in III‐9a)
for the following raw material inputs:
Procurement method
Input
Share of total raw
material costs
(percent)
Primarily
purchased by
your firm
Primarily
produced by
your firm
Innersprings
Foam or other resilient material
Upholstery materials and ticking
Chemicals and other additives
1
Other material inputs
Total (should sum to 100 percent)
1
0.0
Please indicate any other notable "other" raw materials not expressly identified above and provide
the share of the total raw material costs that they account for: .
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 28
III‐10. Nonrecurring items (charges and gains) included in the subject product financial results.‐‐For
each annual and interim period for which financial results are reported in question III‐9a, please
specify all material (significant) nonrecurring items (charges and gains) in the schedule below,
the specific question III‐9a line item where the nonrecurring items are included, a brief
description of the relevant nonrecurring items, and the associated values (in $1,000), as
reflected in question III‐9a; i.e., if an aggregate nonrecurring item has been allocated to question
III‐9a, only the allocated value amount included in question III‐9a should be reported in the
schedule below. Note: The Commission’s objective here is to gather information only on
material (significant) nonrecurring items which impacted the reported financial results of the
subject product in question III‐9a.
Fiscal years ended‐‐
January‐September
Item
2017
2018
2019
2019
2020
Value ($1,000)
Nonrecurring item 1
Nonrecurring item 2
Nonrecurring item 3
Nonrecurring item 4
Nonrecurring item 5
Nonrecurring item 6
Nonrecurring item 7
Nonrecurring item: In this table please provide a brief description of each nonrecurring item reported
above and indicate the specific line item in question III‐9a where the nonrecurring item is classified.
Income statement classification of the
Description of the nonrecurring item
nonrecurring item
Nonrecurring item 1
Nonrecurring item 2
Nonrecurring item 3
Nonrecurring item 4
Nonrecurring item 5
Nonrecurring item 6
Nonrecurring item 7
III‐11. Classification of identified nonrecurring items (charges and gains) in the accounting books and
records of the company.‐‐If non‐recurring items were reported in question III‐10 above, please
identify where your company recorded these items in your accounting books and records in the
normal course of business; i.e., just as responses to question III‐10 identify where these items
are reported in question III‐9a.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 29
III‐12a. Asset values.‐‐Report the total assets (i.e., both current and long‐term assets) associated with
the production, warehousing, and sale of mattresses. If your firm does not maintain some or all
of the specific asset information necessary to calculate total assets for mattresses in the normal
course of business, please estimate this information based upon a method (such as production,
sales, or costs) that is consistent with relevant cost allocations in question III‐9a. Provide data as
of the end of your firm’s three most recently completed fiscal years.
Note: Total assets should reflect net assets after any accumulated depreciation and allowances
deducted. If these assets are also related to other products, total assets should be allocated to
the subject products.
Value (in $1,000)
Fiscal years ended‐‐
Item
2017
Total assets (net)
2018
2019
III‐12b. Description of reported assets.‐‐ Please describe the main asset categories (both current and
long‐term assets) in the above response. Provide a brief explanation if there were any
substantial changes in total asset value during the period; e.g., due to asset write‐offs,
revaluation, and major purchases.
III‐13a. Capital expenditures and research and development expenses.—Please report your firm’s
capital expenditures and research and development (“R&D”) expenses for mattresses. Provide
data for your firm’s three most recently completed fiscal years, and for the specified interim
periods.
Value (in $1,000)
Fiscal years ended‐‐
Item
Capital expenditures
R&D expenses
2017
2018
January‐September
2019
2019
III‐13b. Description of reported capital expenditures.—Please describe the nature, focus, and
significance of your firm’s reported capital expenditures in the above response. If no capital
expenditure data were reported or there were any substantial changes in your firm’s capital
expenditures during the period, explain the reason.
2020
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 30
III‐13c. Description of reported R&D expenses.—Please describe the nature, focus, and significance of
your firm’s reported R&D expenses in the response above. If no R&D expense data were
reported or there were any substantial changes in your firm’s R&D expenses during the period,
explain the reason.
III‐14. Data consistency and reconciliation.‐‐Please indicate whether your firm’s financial data for
questions III‐9a, 12a, and 13a are based on a calendar year or on your firm’s fiscal year:
Calendar year
Fiscal year Specify fiscal year
Please note the quantities and values reported in question III‐9a should reconcile with the data
reported in question II‐7 (including export shipments) as long as they are reported on the same
calendar year basis.
RECONCILIATION OF TRADE VS FINANCIAL DATA.‐‐Please ensure that the quantities and values reported
for total shipments in Part II equal the quantities and values reported for total net sales in Part III of this
questionnaire in each time period unless the financial data from Part III are reported on a fiscal year
basis, in which case only the interim periods must reconcile. If the calculated fields below return values
other than zero (i.e., “0”) and both are being reported on a calendar basis, please explain the discrepancy
below.
Fiscal years ended‐‐
January‐September
Reconciliation
2017
Quantity: Trade data from question
II‐7 (lines D, F, H, and J) less financial
total net sales quantity data from
question III‐9a, = zero ("0").
2018
0
2019
0
2019
0
Value: Trade data from question II‐7
(lines E, G, I, and K) less financial
total net sales value data from
question III‐9a, = zero ("0").
0
0
0
Do these data in question III‐9a reconcile with data in question II‐7?
Yes
No
If no, please explain.
2020
0
0
0
0
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 31
If your responses to any of the items in questions III‐15, III‐16, and III‐17 differ by country, please
describe these differences and, as applicable, indicate which country or countries your response refers
to in the relevant form fields.
III‐15. Effects of imports on investment.‐‐Since January 1, 2017, has your firm experienced any actual
negative effects on its return on investment or the scale of capital investments as a result of
imports of mattresses from Cambodia, China, Indonesia, Malaysia, Serbia, Thailand, Turkey,
and/or Vietnam?
No
Yes
If yes, my firm has experienced actual negative effects as follows.
(check as many as appropriate)
(please describe)
Cancellation,
postponement, or
rejection of expansion
projects
Denial or rejection of
investment proposal
Reduction in the size of
capital investments
Return on specific
investments negatively
impacted
Other
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 32
III‐16. Effects of imports on growth and development.‐‐Since January 1, 2017, has your firm
experienced any actual negative effects on its growth, ability to raise capital, or existing
development and production efforts (including efforts to develop a derivative or more advanced
version of the product) as a result of imports of mattresses from Cambodia, China, Indonesia,
Malaysia, Serbia, Thailand, Turkey, and/or Vietnam?
No
Yes
If yes, my firm has experienced actual negative effects as follows.
(check as many as appropriate)
(please describe)
Rejection of bank loans
Lowering of credit rating
Problem related to the
issue of stocks or bonds
Ability to service debt
Other
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 33
III‐17. Anticipated effects of imports.‐‐Does your firm anticipate any negative effects due to imports of
mattresses from Cambodia, China, Indonesia, Malaysia, Serbia, Thailand, Turkey, and/or
Vietnam?
No
Yes
If yes, my firm anticipates negative effects as follows.
III‐18. Effects on financial performance of COVID‐19.‐‐ Please explain how the COVID‐19 pandemic has
affected the financial performance of your firm’s mattresses operations as reported in III‐9a.
III‐19. Other explanations.‐‐If your firm would like to further explain a response to a question in Part III
for which a narrative box was not provided, please note the question number and the
explanation in the space provided below. Please also use this space to highlight any issues your
firm had in providing the data in this section, including but not limited to technical issues with
the MS Word questionnaire.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 34
PART IV.‐‐PRICING AND MARKET FACTORS
Further information on this part of the questionnaire can be obtained from John Benedetto (202‐205‐
3270, [email protected]).
IV‐1. Contact information.‐‐Please identify the individual that Commission staff may contact
regarding the confidential information submitted in Part IV.
Name
Title
Email
Telephone
PRICE DATA
IV‐2. This question requests quarterly quantity and value data for your firm’s commercial shipments
to unrelated U.S. customers since January 1, 2017 of the following products produced by your
firm.
Product 1.— Memory foam mattress (without any innersprings), queen size, height (edge to
edge) greater than or equal to 8.0 inches but less than 10.0 inches. Foam density
in a top/comfort layer of greater than equal to 3 lbs per cubic foot but less than or
equal 5 lbs per cubic foot. Shipped as a Mattress in a Box.
Product 2.‐‐ Memory foam mattress (without any innersprings), queen size, height (edge to
edge) greater than or equal to 8.0 inches but less than 10.0 inches. Foam density
in a top/comfort layer of greater than equal to 3 lbs per cubic foot but less than or
equal 5 lbs per cubic foot. Shipped as a flat pack mattress.
Product 3.— Memory foam mattress (without any innersprings), queen size, height (edge to
edge) greater than or equal to 10.0 inches but less than 12.0 inches. Foam density
in a top/comfort layer of greater than equal to 2 lbs per cubic foot but less than 3
lbs per cubic foot. Shipped as a Mattress in a Box.
Product 4.— Memory foam mattress (without any innersprings), queen size, height (edge to
edge) greater than or equal to 10.0 inches but less than 12.0 inches. Foam density
in a top/comfort layer of greater than equal to 2 lbs per cubic foot but less than 3
lbs per cubic foot. Shipped as a flat‐pack mattress.
Product 5.— “Wrapped” innerspring mattress (including mattresses with multiple cores and/or
foam in addition to the innerspring), queen size, height (edge to edge) greater
than or equal to 9.0 inches but less than or equal to 12.0 inches. Coil count less
than 1200 coils in Queen size. Shipped as a Mattress in a Box.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 35
Product 6.— “Wrapped” innerspring mattress (including mattresses with multiple cores and/or
foam in addition to the innerspring), queen size, height (edge to edge) greater
than or equal to 9.0 inches but less than or equal to 12.0 inches. Coil count less
than 1200 coils in Queen size. Shipped as a flat pack mattress.
Product 7.‐‐ Open/non‐wrapped innerspring mattress (including mattresses with multiple cores
and/or foam in addition to the innerspring), queen size, height (edge to edge)
greater than or equal to 9.0 inches but less than or equal to 12.0 inches. Coil count
less than 1200 coils in Queen size. Shipped as a flat pack mattress.
Product 8.‐‐ Foam mattress (without any innersprings), with a width exceeding 27 inches, a
length exceeding 51 inches, and a depth between 1.0 inches and 6.0 inches
inclusive, on a nominal basis, typically designed to fit U.S. standard full size cribs.
Please note that values should be f.o.b., U.S. point of shipment and should not include U.S.‐inland
transportation costs. Values should reflect the final net amount paid to your firm (i.e., should be net
of all deductions for discounts or rebates).
IV‐2a. During January 2017‐September 2020, did your firm produce and sell to unrelated U.S. customers
any of the above listed products (or any products that were competitive with these products)?
Yes.‐‐Please complete the following pricing data table(s) as appropriate.
No.‐‐Skip to question IV‐3.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 36
IV‐2b. Price data.‐‐Report below the quarterly price data1 for pricing products2 produced and sold by
your firm.
Report data in number of mattresses and actual dollars (not 1,000s).
(Quantity in number of mattresses, value in dollars)
Product 1
(Mattress in a Box)
Period of shipment
2017:
January‐March
Quantity
Value
Product 2
(Flat‐pack Mattress)
Quantity
Value
Product 3
(Mattress in a Box)
Quantity
Value
Product 4
(Flat‐pack Mattress)
Quantity
Value
April‐June
July‐September
October‐December
April‐June
July‐September
October‐December
April‐June
July‐September
October‐December
April‐June
July‐September
2018:
January‐March
2019:
January‐March
2020:
January‐March
1 Net values (i.e., gross sales values less all discounts, allowances, rebates, prepaid freight, and the value of returned goods), f.o.b. your firm’s U.S.
point of shipment. Please subtract any discounts, rebates, and returns from the quarter in which the sale occurred.
2 Pricing product definitions are provided on the first page of Part IV.
Note.‐‐If your firm’s product does not exactly meet the product specifications but is competitive with the specified product, provide a description of
your firm’s product. Also, please explain any anomalies in your firm’s reported pricing data.
Product 1:
Product 2:
Product 3:
Product 4:
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 37
IV‐2b. Price data.—Continued. Report below the quarterly price data1 for pricing products2 produced
and sold by your firm.
Report data in number of mattresses and actual dollars (not 1,000s).
(Quantity in number of mattresses, value in dollars)
Product 5
(Mattress in a Box)
Period of shipment
2017:
January‐March
Quantity
Value
Product 6
(Flat‐pack Mattress)
Product 7
(Flat‐pack Mattress)
Quantity
Quantity
Value
Value
Product 8
Quantity
Value
April‐June
July‐September
October‐December
April‐June
July‐September
October‐December
April‐June
July‐September
October‐December
April‐June
July‐September
2018:
January‐March
2019:
January‐March
2020:
January‐March
1 Net values (i.e., gross sales values less all discounts, allowances, rebates, prepaid freight, and the value of returned goods), f.o.b. your firm’s U.S.
point of shipment. Please subtract any discounts, rebates, and returns from the quarter in which the sale occurred.
2 Pricing product definitions are provided on the first page of Part IV.
Note.‐‐If your firm’s product does not exactly meet the product specifications but is competitive with the specified product, provide a description of
your firm’s product. Also, please explain any anomalies in your firm’s reported pricing data.
Product 5:
Product 6:
Product 7:
Product 8:
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 38
IV‐2c. Price data checklist.‐‐Please check that the pricing data in question IV‐2(b) has been correctly
reported.
Are the price data reported above:
√ if Yes
In actual dollars (not $1,000)?
F.o.b. U.S. point of shipment (i.e., does not include U.S. transport costs)?
Net of all discounts and rebates?
Have discounts, rebates, and returns been credited to the quarter in which the
sale occurred?
Quantities do not exceed commercial shipments in part II in each year?
IV‐2d. Pricing data methodology.‐‐Please describe the method and the kinds of documents/records
that were used to compile your price data.
Note: As requested in Part I of this questionnaire, please keep all supporting documents/records used in
the preparation of the price data, as Commission staff may contact your firm regarding questions on the
price data. The Commission may also request that your company submit copies of the supporting
documents/records (such as sales journal, invoices, etc.) used to compile these data.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
IV‐3.
Page 39
Price setting.‐‐How does your firm determine the prices that it charges for sales of mattresses
(check all that apply)? If your firm issues price lists, please submit sample pages of a recent list.
Transaction
by
transaction
Contracts
IV‐4.
Other
If other, describe
Discount policy.‐‐Please indicate and describe your firm’s discount policies (check all that apply).
Annual
total
volume
discounts
Quantity
discounts
IV‐5.
Set
price
lists
No
discount
policy
Other
Describe
Pricing terms.‐‐On what basis are your firm’s prices of domestic mattresses usually quoted
(check one)?
Delivered
F.o.b.
IV‐6.
If f.o.b., specify point
Contract versus spot.‐‐Approximately what share of your firm’s sales of its U.S.‐produced
mattresses in 2019 was on a (1) short‐term contract basis, (2) annual contract basis, (3) long‐
term contract basis, and (4) spot sales basis?
Item
Share of 2019
sales
Short‐term
contracts
(multiple
deliveries for
less than 12
months)
%
Type of sale
Long‐term
Annual
contracts
contracts
(multiple
(multiple
deliveries for
deliveries for 12
more than 12
months)
months)
%
%
Spot sales
(for a single
delivery)
%
Total
(should
sum to
100.0%)
0.0
%
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
IV‐7.
Page 40
Contract provisions.‐‐Please fill out the table regarding your firm’s typical sales contracts for
U.S.‐produced mattresses (or check “not applicable” if your firm does not sell on a short‐term,
annual and/or long‐term contract basis).
Short‐term contracts Annual contracts
(multiple
(multiple deliveries
deliveries for 12
for less than 12
months)
months)
Long‐term contracts
(multiple deliveries
for more than 12
months)
Typical sales
contract provisions
Item
Average contract
duration
No. of
days
Price renegotiation
(during contract
period)
Yes
No
Quantity
Price
Both
Yes
No
Fixed quantity
and/or price
Indexed to raw
material costs1
Not applicable
365
1
Please identify the indexes used: .
IV‐8.
Lead times.‐‐What share of your firm’s sales is from inventory and produced to order and what
is the typical lead time between a customer’s order and the date of delivery for your firm’s sales
of its U.S.‐produced mattresses?
Lead time (Average
Source
Share of 2019 sales number of days)
From inventory
%
Produced to order
%
Total (should sum to 100.0%)
0.0 %
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
IV‐9.
Page 41
Shipping information.‐‐
(a)
(b)
Who generally arranges the transportation to your firm’s customers’ locations?
Your firm Purchaser (check one)
Indicate the approximate percentage of your firm’s sales of mattresses that are
delivered the following distances from its production facility.
Distance from production facility
Share
Within 100 miles
%
101 to 1,000 miles
%
Over 1,000 miles
%
Total (should sum to 100.0%)
0.0 %
IV‐10. Geographical shipments.‐‐In which U.S. geographic market area(s) has your firm sold or
internally consumed/transferred its U.S.‐produced mattresses since January 1, 2017 (check all
that apply)?
Geographic area
√ if applicable
Northeast.–CT, ME, MA, NH, NJ, NY, PA, RI, and VT.
Midwest.–IL, IN, IA, KS, MI, MN, MO, NE, ND, OH, SD, and WI.
Southeast.–AL, DE, DC, FL, GA, KY, MD, MS, NC, SC, TN, VA, and WV.
Central Southwest.–AR, LA, OK, and TX.
Mountains.–AZ, CO, ID, MT, NV, NM, UT, and WY.
Pacific Coast.–CA, OR, and WA.
Other.–All other markets in the United States not previously listed,
including AK, HI, PR, and VI.
IV‐11. Inland transportation costs.—What is the approximate percentage of the cost of U.S.‐produced
mattresses that is accounted for by U.S. inland transportation costs? percent
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 42
IV‐12. Private label shipments.—
(a) Does your firm produce private label mattresses, i.e., mattresses sold to a purchaser for sale
at retail under the purchaser’s own brand name?
No
Yes
If yes, please estimate the approximate number of private label
mattresses your firm produced and sold in 2019.
(b) Since January 1, 2017, has your firm refused to supply private label mattresses, or limited
supplies of private label mattresses, to any wholesale purchaser, for example, because the
purchaser sells its private label mattresses in competition with your own‐brand mattresses
to the same retail customers?
No
Yes
If yes, please describe the circumstances and any limitations or conditions
placed on purchasers of private label mattresses made by your firm.
IV‐13. Substitutes.‐‐Can other products be substituted for mattresses?
No
Yes‐‐Please fill out the table.
Substitute
End use in which this
substitute is used
Have changes in the price of this substitute
affected the price for mattresses?
No Yes
1.
2.
3.
Explanation
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 43
IV‐14. Demand trends.—
(a) Indicate how demand within the United States and outside of the United States (if known) for
inner‐spring, non‐innerspring (i.e. foam), hybrid, MiB, and flat shipped non‐MiB mattresses has
changed since January 1, 2017. Explain any trends and describe the principal factors that have
affected these changes in demand, including any effects from COVID‐19.
Market
Overall
No
Overall Fluctuate with
increase change decrease no clear trend
Explanation and factors
Current demand
Within the United States
Innerspring
Non‐innerspring
Hybrid
Rolled and
compressed MiBs
Innerspring
Non‐innerspring
Hybrid
Rolled and
compressed MiBs
Flat shipped non‐MiB
mattresses
Other (describe:
)
Outside the United States
Flat shipped non‐MiB
mattresses
Other (describe:
)
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 44
IV‐14. Demand trends.‐‐Continued
(b) Please also indicate how you anticipate demand will change during the remainder of 2020 and
2021 for the various mattress types listed in part (a). Explain any trends and describe the
principal factors that will affect these changes in demand, including any effects from COVID‐19.
Market
Overall
No
Overall Fluctuate with
increase change decrease no clear trend
Explanation and factors
Anticipated future demand during 2020‐21
Within the United States
Innerspring
Non‐innerspring
Hybrid
Rolled and
compressed MiBs
Innerspring
Non‐innerspring
Hybrid
Rolled and
compressed MiBs
Flat shipped non‐MiB
mattresses
Other (describe:
)
Outside the United States
Flat shipped non‐MiB
mattresses
Other (describe:
)
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 45
IV‐15. Product changes.‐‐ Have there been any significant changes in the product range, product mix,
or marketing of mattresses since January 1, 2017 (please respond for each item)?
Item
No
Yes If yes, please describe.
MiBs (i.e., “bed(s) in a box,”
“mattress(es) in a box,” and/or
“compressed mattress(es).”)
Other direct‐to‐consumer internet
sales
Branding
Private label
programs
Floor slots at brick and mortar
retailers
Location of products in consumer
search results on e‐commerce sites
Other
IV‐16. Conditions of competition.‐‐
(a) Is the mattresses market subject to business cycles (other than general economy‐wide
conditions) and/or other conditions of competition distinctive to mattresses? If yes,
describe.
Check all that apply.
Please describe.
No
Skip to question IV‐17.
Yes‐Business cycles (e.g.
seasonal business)
Yes‐Other distinctive
conditions of competition
(b) If yes, have there been any changes in the business cycles or conditions of competition for
mattresses since January 1, 2017?
No
Yes
If yes, describe.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 46
IV‐17. Supply constraints.‐‐Has your firm refused, declined, or been unable to supply mattresses since
January 1, 2017 (examples include placing customers on allocation or “controlled order entry,”
declining to accept new customers or renew existing customers, delivering less than the
quantity promised, being unable to meet timely shipment commitments, etc.)?
No
Yes
If yes, please describe.
IV‐18. Raw materials.‐‐How have mattresses raw material prices changed since January 1, 2017?
Fluctuate
with no
Overall
No
Overall
increase change decrease clear trend
Explain, noting how raw material price changes
have affected your firm’s selling prices for
mattresses.
IV‐19. Marketing practices by brick and mortar retailers.‐‐If your firms sells mattresses through brick
and mortar retail establishments, please explain the factors that determine the selection of
mattresses that are displayed on the floor of such establishments and their location on the sales
floors of such establishments (e.g., sales velocity, quality, reviews, supplier relationships, profit
margins, etc.), as well as the relative importance of each factor.
IV‐20. Marketing practices by internet retailers.‐‐If your firm sells mattresses over an e‐commerce
website, please explain the factors that determine the rankings of mattresses yielded by
consumer search results on the website (e.g., sales velocity, quality, delivery time, customer
reviews, price, etc.) and the relative importance of each factor to the search results.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 47
IV‐21. Floor space allocation and e‐commerce placement changes.‐‐Has the allocation of floor space
for mattresses and/or e‐commerce placement (i.e., prominence or ranking on websites) of
mattresses changed since January 1, 2017 with respect to mattresses from the United States,
Cambodia, China, Indonesia, Malaysia, Serbia, Thailand, Turkey, Vietnam, other countries, and
overall?
Increase
No
change
Fluctuate
with no
clear
Not
applicable
Decrease trend
Explanation and factors
Floor space allocation
United States
Cambodia
China
Indonesia
Malaysia
Serbia
Thailand
Turkey
Vietnam
Other countries1
Overall
United States
Cambodia
China
Indonesia
Malaysia
Serbia
Thailand
Turkey
Vietnam
Other countries1
Overall
E‐commerce placement
1
Please identify these other countries: .
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 48
IV‐22. Interchangeability.‐‐Are mattresses produced in the United States and in other countries
interchangeable (i.e., can they physically be used in the same applications)?
Please indicate A, F, S, N, or 0 in the table below:
A = the products from a specified country‐pair are always interchangeable
F = the products are frequently interchangeable
S = the products are sometimes interchangeable
N = the products are never interchangeable
0 = no familiarity with products from a specified country‐pair
Country‐
pair
United
States
Turkey
Vietnam
Other
countries
Cambodia
China
Indonesia Malaysia Serbia Thailand
Cambodia
China
Indonesia
Malaysia
Serbia
Thailand
Turkey
Vietnam
For any country‐pair producing mattresses that are sometimes or never interchangeable, identify the country‐pair and
explain the factors that limit or preclude interchangeable use:
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 49
IV‐23. Factors other than price.‐‐Are differences other than price (e.g., quality, availability,
transportation network, product range, technical support, etc.) between mattresses produced in
the United States and in other countries a significant factor in your firm’s sales of the products?
Please indicate A, F, S, N, or 0 in the table below:
A = such differences are always significant
F = such differences are frequently significant
S = such differences are sometimes significant
N = such differences are never significant
0 = no familiarity with products from a specified country‐pair
Country‐
pair
United
States
Turkey
Vietnam
Other
countries
Cambodia
China
Indonesia Malaysia Serbia Thailand
Cambodia
China
Indonesia
Malaysia
Serbia
Thailand
Turkey
Vietnam
For any country‐pair for which factors other than price always or frequently are a significant factor in your firm’s sales
of mattresses, identify the country‐pair and report the advantages or disadvantages imparted by such factors:
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 50
IV‐24. Impact of the section 301 actions.‐‐This question concerns the section 301 investigation and
subsequent announcement of additional tariffs that apply to mattresses imported from China,
which were proposed and implemented by the United States in response to Chinese trade
practices. Did the imposition of tariffs on Chinese‐origin products under section 301 have an
impact on the mattresses market in the United States?
Yes— Please indicate the
impact in the table below.
No
Don’t know
Factor
Fluctuate Explain, noting how the imposition
with no of tariffs under section 301 affected
each factor of the mattresses
clear
Overall
No
Overall
market in the United States.
trend
increase change decrease
Supply of U.S.‐
produced mattresses
Supply of mattresses
imported from China
Supply of mattresses
imported from other
countries
Prices for mattresses
Overall U.S. demand
for mattresses
Raw material costs for
mattresses
IV‐25. Impact of the 2019 antidumping duties on mattresses from China.— Please describe briefly the
impact, if any, that the antidumping duty order imposed on mattresses from China has had on
the U.S. market for mattresses since December 16, 2019.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 51
IV‐26. Customer identification.‐‐List the names and contact information for your firm’s 10 largest U.S.
customers for mattresses since January 1, 2017. Indicate the share of the quantity of your firm’s
total shipments of mattresses that each of these customers accounted for in 2019.
Customer’s name
City
State
Share of 2019 sales
(%)
1
2
3
4
5
6
7
8
9
10
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 52
IV‐27. Competition from imports.‐‐
(a)
Lost revenue.‐‐Since January 1, 2017: To avoid losing sales to competitors selling
mattresses from Cambodia, China, Indonesia, Malaysia, Serbia, Thailand, Turkey, and/or
Vietnam, did your firm:
Item
No
Yes
(b)
Reduce prices
Roll back announced price increases
Lost sales.‐‐Since January 1, 2017: Did your firm lose sales of mattresses to imports of
this product from Cambodia, China, Indonesia, Malaysia, Serbia, Thailand, Turkey,
and/or Vietnam?
No
Yes
IV‐28. Other explanations.‐‐If your firm would like to further explain a response to a question in Part
IV for which a narrative response box was not provided, please note the question number and
the explanation in the space provided below. Please also use this space to highlight any issues
your firm had in providing the data in this section, including but not limited to technical issues
with the MS Word questionnaire.
Business Proprietary
U.S. Producers’ Questionnaire ‐ Mattresses (Final)
Page 53
HOW TO FILE YOUR QUESTIONNAIRE RESPONSE
This questionnaire is available as a “fillable” form in MS Word format on the
Commission’s website at:
https://usitc.gov/investigations/701731/2020/mattresses_cambodia_china_indonesia_
malaysia/final.htm
Please do not attempt to modify the format or permissions of the questionnaire
document. Please submit the completed questionnaire using one of the methods noted
below. If your firm is unable to complete the MS Word questionnaire or cannot use one
of the electronic methods of submission, please contact the Commission for further
instructions.
• Upload via Secure Drop Box.—Upload the MS Word questionnaire along with a scanned copy of the
signed certification page (page 1) through the Commission’s secure upload facility:
Web address: https://dropbox.usitc.gov/oinv/
Pin: MATT
• E‐mail.—E‐mail the MS Word questionnaire to [email protected]; include a scanned copy of the
signed certification page (page 1). Submitters are strongly encouraged to encrypt nonpublic documents
that are electronically transmitted to the Commission to protect your sensitive information from
unauthorized disclosure. The USITC secure drop‐box system and the Electronic Document Information
System (EDIS) use Federal Information Processing Standards (FIPS) 140‐2 cryptographic algorithms to
encrypt data in transit. Submitting your nonpublic documents by a means that does not use these
encryption algorithms (such as by email) may subject your firm’s nonpublic information to unauthorized
disclosure during transmission. If you choose a non‐encrypted method of electronic transmission, the
Commission warns you that the risk of such possible unauthorized disclosure is assumed by you and not
by the Commission.
If your firm does not produce this product, please fill out page 1, print, sign, and submit a scanned copy
to the Commission.
Parties to this proceeding.—If your firm is a party to this proceeding, it is required to serve a copy of the
completed questionnaire on parties to the proceeding that are subject to administrative protective
order (see 19 CFR § 207.7). A list of such parties may be obtained from the Commission’s Secretary (202‐
205‐1803). A certificate of service must accompany the completed questionnaire you submit (see 19 CFR
§ 207.7). Service of the questionnaire must be made in paper form.
| File Type | application/pdf |
| File Title | Microsoft Word - US Producer--Mattresses (F) |
| Author | mary.messer |
| File Modified | 2020-11-23 |
| File Created | 2020-11-23 |